Prelude Capital Management’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Prelude Capital Management’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-108,225	Closed	-$5K	–	1863
2022 Q3	$5K	Hold	108,225	–	–	﹤0.01%	1370
2022 Q2	$9K	Hold	108,225	–	–	﹤0.01%	1586
2022 Q1	$22K	Hold	108,225	–	–	﹤0.01%	1537
2021 Q4	$60K	Hold	108,225	–	–	﹤0.01%	1768
2021 Q3	$63K	Hold	108,225	–	–	﹤0.01%	1538
2021 Q2	$92K	Buy	+108,225	New	+$69.2K	﹤0.01%	1488

Prelude Capital Management's SHACW Position: Q4 2022 in Review

Prelude Capital Management sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 108,225 shares — an estimated $5K sold.

Prelude Capital Management first reported a position in SHACW in Q2 2021 and held it in 6 quarters. The position peaked at $92K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

Prelude Capital Management reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 108,225 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $5K.
Prelude Capital Management first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q2 2021 and held it in 6 quarters.
Prelude Capital Management's SCP & CO Healthcare Acquisition Company Warrant position peaked at $92K in Q2 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.